Merck KGaA plans to discontinue operations at its production plant in Arklow, Ireland, “by the end of 2028,” a company spokesperson confirmed to Fierce Pharma. The decision follows a strategic review of the products made at the site, which prompted Merck KGaA to “discontinue” its API portfolio there, the spokesperson explained.
Merck KGaA to mothball operations at Ireland API plant by end of 2028
Latest from Blog
Fuel Meals Launches Specialized GLP-1 Meal Plans Built Around Protein-First Nutrition and Appetite Changes
PENNS GROVE, N.J.–(BUSINESS WIRE)–Nov 3, 2026– Post Views: 0
Always Hungry After Dinner? Experts Say to Eat This Snack in the Afternoon to Curb Cravings
This might save you from that second bowl of midnight ice cream. Post Views: 0
Food for Thought with Kat: Sleep dreams
A nutrition columnist explains sleep’s role in metabolism and health, shares natural sleep remedies and offers a stuffed delicata squash recipe. Post Views: 0
Barbara Intermill, On Nutrition: What food costs
Just a little over 1% of our U.S. population grows and produces the food that the rest of us expect to be there when we walk into a grocery store or restaurant,
Food scores or warning labels? New study offers clues for Europe’s nutrition labeling debate
A German–Israeli eye-tracking study found that both the design and familiarity of front-of-package nutrition labels shape what consumers notice and how they interpret food products. Participants in both … Post Views: 0